{"nctId":"NCT01528709","briefTitle":"Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)","startDateStruct":{"date":"2012-03"},"conditions":["Saphenous Vein Graft Disease"],"count":173,"armGroups":[{"label":"High-dose statin therapy","type":"EXPERIMENTAL","interventionNames":["Drug: Atorvastatin 80 mg daily"]},{"label":"Moderate-dose statin therapy","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Atorvastatin 10 mg daily"]}],"interventions":[{"name":"Atorvastatin 80 mg daily","otherNames":[]},{"name":"Atorvastatin 10 mg daily","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients undergoing first-time CABG with at least 1 saphenous vein graft\n\nExclusion Criteria:\n\n* Redo-CABG\n* Statin allergy\n* Severe renal dysfunction\n* Severe liver disease","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Saphenous Vein Graft Occlusion (Percentage of Vein Grafts Occluded) Based on CT Coronary Angiography at 1 Year","description":"Vein graft patency will be assessed in a blinded fashion by CT coronary angiography 1 year after CABG","paramType":"COUNT_OF_UNITS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"14","spread":null},{"groupId":"OG001","value":"16","spread":null}]}]}]},{"type":"SECONDARY","title":"Vein Graft Stenosis 1 Year After CABG Based on CT Coronary Angiography","description":"Vein graft stenosis 1 year after CABG based on CT coronary angiography","paramType":"COUNT_OF_UNITS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":5,"n":86},"commonTop":[]}}}